IP Library › Assignment 029793/0152
Patent Assignment
Reel/Frame 029793/0152

Change of Name

Recorded: 2013-02-11 Pages: 4
Assignor
SMITHKLINE BEECHAM CORPORATION
Executed: 2009-10-27
Assignee
GLAXOSMITHKLINE LLC
ONE FRANKLIN PLAZA, 200 NORTH 16TH STREET, PHILADELPHIA, PENNSYLVANIA, 19102
Covered Properties (7)
Radioimmunotherapy of Lymphoma Using Anti-CD20 Antibodies
Patent: 5,595,721 →
Application: 08/121,582 →
Radioimmunotherapy of Lymphoma Using Anti-CD20 Antibodies
Patent: 5,843,398 →
Application: 08/639,882 →
Radioimmunotherapy of Lymphoma Using Anti-CD20 Antibodies
Patent: 6,015,542 →
Application: 08/711,527 →
Radioimmunotherapy of Lymphoma Using Anti-CD20 Antibodies
Patent: 6,090,365 →
Application: 08/972,900 →
Radioimmunotherapy of Lymphoma Using Anti-CD20 Antibodies
Patent: 6,287,537 →
Application: 09/087,392 →
Radioimmunotherapy of Lymphoma Using Anti-CD20 Antibodies
Patent: 6,565,827 →
Application: 09/924,360 →
Patient-Specific Dosimetry
Patent: 7,668,662 →
Application: 11/200,688 →
Publication: US 2005/0288869
Related Assignments (1)
Other recorded transfers of the patents in this record — the chain of ownership.
Confirmatory License Jun 8, 2016
From: UNIVERSITY OF MICHIGAN
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 038914/0161 →